The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis
Abstract
OBJECTIVES: Biliary strictures, similar to primary sclerosing cholangitis (PSC), have been reported in patients with autoimmune pancreatitis, which is characterized by elevated serum IgG4 levels and responsiveness to corticosteroids. We sought to determine the frequency of elevated IgG4 in patients with PSC and to clinically compare PSC patients with elevated and normal IgG4 levels. METHODS: We measured serum IgG4 in 127 patients with PSC and 87 patients with primary biliary cirrhosis, as disease controls. Demographic, clinical, and laboratory characteristics were compared between the PSC groups with normal and elevated IgG4 (>140 mg/dL). RESULTS: Elevated IgG4 was found in 12 PSC patients (9%) versus one PBC patient (1.1%) (p= 0.017). Patients with elevated IgG4 had higher total bilirubin (p= 0.009), alkaline phosphatase (p= 0.01), and PSC Mayo risk score (p= 0.038), and lower frequency of IBD (p < 0.0001). Importantly, the time to liver transplantation was shorter in patients with elevated IgG4 (1.7 vs 6.5 yr, p= 0.0009). The type of biliary involvement (intrahepatic, extrahepatic, or both) and pancreatic involvement were similar in both groups. CONCLUSIONS: A small proportion of PSC patients had elevated serum IgG4. In these patients parameters of liver disease severity were more pronounced and time to liver transplantation was shorter, suggesting a more severe disease course. It is possible that this subset of patients behaves similarly to autoimmune pancreatitis patients with biliary strictures, and could potentially respond to corticosteroids. Testing PSC patients for IgG4 and treating those with elevated levels with corticosteroids in clinical trials should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
Hamano, H., Kawa, S., Horiuchi, A., Unno, H., Furuya, N., Akamatsu, T., Fukushima, M., Nikaido, T., Nakayama, K., Usuda, N., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441005 · Cited by 2,705
A new clinicopathological entity of IgG4-related autoimmune disease
Kamisawa, T., Funata, N., Hayashi, Y., Eishi, Y., Koike, M., Tsuruta, K., Okamoto, A., Egawa, N., & Nakajima, H. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1175-y · Cited by 1,457
Yoshida, K., Toki, F., Takeuchi, T., Watanabe, S.-I., Shiratori, K., & Hayashi, N. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02285209 · Cited by 1,430
Kawaguchi, K., Koike, M., Tsuruta, K., Okamoto, A., Tabata, I., & Fujita, N. (1991) · Human Pathology · doi:10.1016/0046-8177(91)90087-6 · Cited by 633
Kojima, S.-I., Watanabe, N., Numata, M., Ogawa, T., & Matsuzaki, S. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-003-1178-8 · Cited by 455
Sclerosing pancreato-cholangitis responsive to steroid therapy
Erkelens, G., Vleggaar, F., Lesterhuis, W., van Buuren, H., & van der Werf, S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00603-0 · Cited by 239
Recent concept of autoimmune-related pancreatitis
Okazaki, K., Uchida, K., & Chiba, T. (2001) · Journal of Gastroenterology · doi:10.1007/s005350170094 · Cited by 152
Oral budesonide in the treatment of primary sclerosing cholangitis
Angulo, P., Batts, K. P., Jorgensen, R. A., LaRusso, N. A., & Lindor, K. D. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02323.x · Cited by 147
Self-citationSchramm, C., Schirmacher, P., Helmreich-Becker, I., Gerken, G., Büschenfelde, K. H. M. Z., & Lohse, A. W. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-12-199912210-00006 · Cited by 109
van Hoogstraten, H. J. F. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01059-5 · Cited by 107
Cited by
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., Petta, S., & Thiele, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.025 · Cited by 1,925
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Kamisawa, T., Zen, Y., Pillai, S., & Stone, J. H. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60720-0 · Cited by 1,212
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy
Ghazale, A., Chari, S. T., Zhang, L., Smyrk, T. C., Takahashi, N., Levy, M. J., Topazian, M. D., Clain, J. E., Pearson, R. K., Petersen, B. T., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.009 · Cited by 890
Self-citation
Metadata
- Authors
- Mendes, F. D., Jorgensen, R., Keach, J., Katzmann, J. A., Smyrk, T., Donlinger, J., Chari, S., & Lindor, K. D.
- Venue
- The American Journal of Gastroenterology
- Published
- 2006-09
- Volume
- 101
- Issue
- 9
- Pages
- 2070-2075
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W2010215673
- Cited by
- 328
- References
- 12
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis. https://app.cochat.ai/papers/10.1111/j.1572-0241.2006.00772.x
- The paper
- Mendes, F. D., Jorgensen, R., Keach, J., Katzmann, J. A., Smyrk, T., Donlinger, J., Chari, S., & Lindor, K. D. (2006). Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis. The American Journal of Gastroenterology. https://doi.org/10.1111/j.1572-0241.2006.00772.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.